Anish Bhatnagar's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Dec 4, 2023
- Accession no.
- 0001209191-23-057318
- Filed
- Dec 4, 2023
- Trade date
- Nov 30, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $794.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anish BhatnagarCIK 0001614821 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Common Stock | SSaleDisposed | −27,716 | $28.65 | −$794,063.4 | 108,062 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.